Arch Therapeutics Inc (ARTH)

[21money21]

The delays upon delays are killing this company and will have to raise more cash soon. If trials started last year this would be over a dollar easy. As the share count increases the odds of this happening anytime soon are dropping dramatically. Another one of my favorite companies killing us by delays and funding. Not their fault with all the red tape to get started but still resulting in massive amount of shares when All said and done